{"artifact":{"id":"ut-ad-apoe-202604280307","artifact_type":"upstream_target","entity_ids":"[\"APOE\", \"Alzheimer's disease\"]","title":"APOE as upstream causal node in Alzheimer's disease","quality_score":0.85,"created_by":"ad_master_plan_synthesizer","provenance_chain":"[]","content_hash":"148a2f8e5e005114a755d697a04a2a2efbb9a8bf7b30540b1c11a55d0ecba164","metadata":{"_origin":{"url":null,"type":"internal","tracked_at":"2026-04-28T03:07:54.561812"},"disease":"Alzheimer's disease","effect_size":0.38,"target_gene":"APOE","kill_criteria":["APOE4→APOE3 conversion shows no amyloid reduction in Phase 3 trial","APOE isoform switching fails to improve cognitive endpoints at 18 months","Lipid代谢 correction fails to modify disease progression in APOE4 carriers"],"evidence_count":5,"_schema_version":1,"dgidb_categories":["immunotherapy","cell surface"],"evidence_sources":["PMID:35779013","PMID:39642875","PMID:41812941","PMID:33831349","SDA-gap-seaad-v2-20260402032945"],"convergence_score":0.5,"druggability_score":0.55,"upstreamness_score":0.89,"chembl_ligand_count":12,"falsification_weight":0.0,"alphafold_pocket_score":0.68,"identification_strategy":"MR + RCT","mechanistic_plausibility":0.85},"created_at":"2026-04-27T20:07:54.561895-07:00","updated_at":"2026-04-27T20:07:54.561895-07:00","version_number":4,"parent_version_id":null,"version_tag":null,"changelog":null,"is_latest":1,"lifecycle_state":"active","superseded_by":null,"deprecated_at":null,"deprecated_reason":null,"dependencies":null,"market_price":0.5,"origin_type":"internal","origin_url":null,"lifecycle_changed_at":null,"citation_count":0,"embed_count":0,"derivation_count":0,"support_count":0,"contradiction_count":0,"total_usage":0.0,"usage_score":0.5,"usage_computed_at":null,"quality_status":null,"contributors":[],"answers_question_ids":null,"deprecated_reason_detail":null,"deprecated_reason_code":null,"commit_sha":null,"commit_submodule":null,"last_mutated_at":"2026-05-16T14:51:34.657673-07:00","disputed_at":null,"gap_id":null,"mission_id":null,"intrinsic_priority":null,"effective_priority":null,"artifact_id":"0a2a7b38-1ea8-4eab-8d08-70f7d51a6d2e","artifact_dir":null,"primary_filename":null,"accessory_filenames":null,"folder_layout_version":1,"migrated_to_folder_at":null,"hypothesis_id":null,"authorship":{"kind":"human","contributors":[{"role":"author","actor_ref":"ad_master_plan_synthesizer"}]},"epistemic_tier":"T3_provisional","created_by_agent_id":null},"outgoing_links":[],"incoming_links":[{"source_artifact_id":"rp-ad-apoe-202604280307","link_type":"derives_from","strength":1.0,"evidence":"Research plan tests upstream target ut-ad-apoe-202604280307"}],"current_artifact_id":"ut-ad-apoe-202604280307","is_canonical":true,"supersede_chain":["ut-ad-apoe-202604280307"]}